A new study published on the preprint server bioRxiv in June 2020 shows that a candidate spike protein vaccine can induce neutralizing antibodies, antiviral T cell responses, and protection against infection.
from News Medical Medical Research News Feed https://ift.tt/2ZuL5CB
0 Comments